Long-term follow-up reveals high post-treatment mortality among patients with extensively drug-resistant (XDR) tuberculosis in the country of Georgia

Overall mortality and specifically post-treatment mortality were high among patients with XDR-TB. Patients with an unfavorable end-of-treatment outcome had an increased risk of death during follow-up. The findings highlight the need for improved adherence, better tolerated and shorter therapies, and enhanced post-treatment surveillance among patients treated for XDR-TB.

Article: Oxford Academic

Effective surveillance   Healthy patients  
Back


Emerging Antimicrobials and Diagnostics in AMR 2019

International Matchmaking Symposium on 19-20 November, 2019 in Amsterdam, The Netherlands.

More information
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!